Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

NCT02023697 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)

Sponsor

Bayer